Publisher
Springer Nature Singapore
Reference193 articles.
1. Aaltonen K, Amini R-M, Heikkilä P, Aittomäki K, Tamminen A, Nevanlinna H, Blomqvist C (2009) High cyclin b1 expression is associated with poor survival in breast cancer. Br J Cancer 100:1055–1060
2. Abou-Bakr AA, Eldweny HI (2013) P16 expression correlates with basal-like triple-negative breast carcinoma. Ecancermedicalscience 7:317
3. Abubakar M, Guo C, Koka H, Sung H, Shao N, Guida J, Deng J, Li M, Hu N, Zhou B (2019) Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression. NPJ Breast Cancer 5:1–9
4. Ahnström M, Nordenskjöld B, Rutqvist LE, Skoog L, Stål O (2005) Role of cyclin d1 in erbb2-positive breast cancer and tamoxifen resistance. Breast Cancer Res Treat 91:145–151
5. Al-Joudi FS, Iskandar ZA, Rusli J (2008) The expression of p53 in invasive ductal carcinoma of the breast: a study in the north-east states of Malaysia. Med J Malays 63:96–99
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the mechanisms and challenges of cancer drug resistance;Cell Communication and Signaling;2024-02-12
2. Epigenetic Alterations as an Adaptive Response to Chemotherapy;Drug Resistance in Cancer: Mechanisms and Strategies;2024
3. Tumor Microenvironment: Multiway Role in Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024
4. Role of Cancer Stem Cells in Drug Resistance;Drug Resistance in Cancer: Mechanisms and Strategies;2024
5. Mechanisms of Cancer Resistance to Various Therapies;Drug Resistance in Cancer: Mechanisms and Strategies;2024